Interview with Craig Moore, Director, Hahn Healthcare
Can you outline the significance of the current PBS to the industry and in particular the impact it has on service providers to the industry such as Hahn? As service…
Address: Level 7, 50 Berry Street
North Sydney NSW 2060
Tel: 02 9959 5533
Web: http://www.hahnhealthcare.com.au/default.aspx
Hahn Healthcare combines innovative solutions and world-class services with market insight to create value in your business.
Hahn Healthcare offers clients access to: the highest quality people, industry leading solutions, innovative services, and new market opportunities.
Founded in 1994, Hahn Healthcare is a trusted partner with a reputation for excellence.
Innovative solutions. Market insight. Trusted Partnerships.
As a market leader, Hahn Healthcare is a trusted partner of key decision makers in the Australian pharmaceutical and medical device industries.
We are uniquely positioned to identify partner organisations and market opportunities for global healthcare products, including pharmaceutical and medical devices.
Our team partners with international companies to deliver global solutions locally. We provide strategic advice based on deep industry knowledge and create an access point to the Australian market.
Hahn Healthcare helps international companies reduce risk, manage regulatory requirements and create new revenue streams by facilitating the delivery of global solutions to the Australian marketplace.
Hahn Healthcare is committed to excellence. We build partnerships based on integrity, mutual respect and trust. We are transparent, accountable and operate according to the highest professional standards.
Can you outline the significance of the current PBS to the industry and in particular the impact it has on service providers to the industry such as Hahn? As service…
As ASMI President and Managing Director of Galderma, would you please give us a brief overview of the Australian OTC market and Galderma’s role therein? Galderma is a leading player…
What impact have the PBS reforms had on Amgen in Australia? From a company perspective, biotechnology companies exist in a competitive space. They have predominantly niche medicines with significant competitive…
2006 marked a major milestone, with the Pharmaceutical Industry Action Agenda transformed from a Government-industry initiative into an industry-driven agenda, and the resulting creation of the Pharmaceutical Industry Council (PIC).…
One of the hot topics in the industry is the impact of PBS reforms. Can you speak to recent influence of PBS reforms affecting Novotech’s services in Australia? In our…
Pharmacor is one of the newest entities on the Australian pharmaceutical market. Would you please introduce the company to let Pharmaceutical Executive readers understand more about the Pharmacor story? Pharmacare…
Would you please introduce the PBAC and the role it plays in Australia’s pharmaceutical sector? The Pharmaceutical Benefits Advisory Committee (PBAC) is a statutory committee of the Australian government which…
Molteni was created in 1892 and progressively developed a strong manufacturing base, a very active R&D department and a growing international presence. Could you introduce the story behind such achievements?…
To begin, would you please introduce Medicines Australia to Pharmaceutical Executive readers? Medicines Australia is the association that represents the country’s research-based pharmaceutical industry. With approximately 50 members, the organization…
Servier was eligible to receive $7 million in P3 funding; can you tell us how this initiative has helped the company? P3 was not one of the main reasons why…
How will the PBS reforms affect Solvay? The easy answer is: heavily. Fortunately, Solvay’s leading product which is still under patent will not be subject to the full August 1…
What impact will the recent PBS reforms have on Stiefel’s operations in Australia? Stiefel has no products on the PBS at the moment, and although that doesn’t preclude the company…
Many MNCs are having pipeline concerns in the “new era” of post-blockbuster drug development. How is Bayer positioned in this respect? Bayer Schering Pharma has one of the richest pipelines…
See our Cookie Privacy Policy Here
